Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica M Stempel

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Blood Advances|July 28, 2025
Cost-Effectiveness of Upfront vs. Delayed Allogeneic Hematopoietic Stem Cell Transplant for Intermediate Risk AMLAbdulrahman Alhajahjeh, Kishan Patel, Nikolai A Podoltsev, et al.
Blood. Red Cells & Iron|May 4, 2026
Cost-effectiveness of frontline eltrombopag with immunosuppressive therapy for severe aplastic anemiaSatoko Ito, Kunal C Potnis, Ding Quan Ng, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|February 5, 2026
Assessment of Fellowship Didactic Curricula in Hematology/Oncology: Cross-Sectional Findings From the PODCAST-HOF TrialRonak H Mistry, Karine Tawagi, Daniel J Hausrath, et al.
JCO Oncology Practice|May 31, 2025
Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF TrialVivek G Patel, Karine Tawagi, Samantha A Armstrong, et al.
Blood Cancer Journal|June 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE databaseJan Philipp Bewersdorf, Tariq Kewan, Luca Lanino, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Blood Advances|July 28, 2025
Cost-Effectiveness of Upfront vs. Delayed Allogeneic Hematopoietic Stem Cell Transplant for Intermediate Risk AMLAbdulrahman Alhajahjeh, Kishan Patel, Nikolai A Podoltsev, et al.
Blood. Red Cells & Iron|May 4, 2026
Cost-effectiveness of frontline eltrombopag with immunosuppressive therapy for severe aplastic anemiaSatoko Ito, Kunal C Potnis, Ding Quan Ng, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|February 5, 2026
Assessment of Fellowship Didactic Curricula in Hematology/Oncology: Cross-Sectional Findings From the PODCAST-HOF TrialRonak H Mistry, Karine Tawagi, Daniel J Hausrath, et al.
JCO Oncology Practice|May 31, 2025
Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF TrialVivek G Patel, Karine Tawagi, Samantha A Armstrong, et al.
Blood Cancer Journal|June 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE databaseJan Philipp Bewersdorf, Tariq Kewan, Luca Lanino, et al.
Pageof 4